Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Guided Therapeutics, Inc. (GTHP)
USD0.27
-0.01 (-3.57%)
US OTC Healthcare Medical - Devices
Address
5835 Peachtree Corners East 30092
Norcross, GA, US
Norcross, GA, US
CEO
Mark L. Faupel
Website
guidedinc.com
IPO
2021-01-08
CIK 924515 ISIN US40171F5017
Description
Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.27
-0.01 (-3.57%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
14.1K
Beta
0.73
Float Shares
31.30M
Free Float %
40.8%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -13.04% | +0.00% | +0.00% | -48.70% | -0.50% | -62.96% | +60.00% | +25.00% | -73.84% | -43.27% | -43.27% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.27
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-135.37
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+10,857.1% ★
-
EPS growth Medical - Devices: +28.5%+5.5% Q1'26: -47.1% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-274.1%
-
EBIT margin Medical - Devices: +6.2%-336.3%
-
ROIC Medical - Devices: +3.3%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+36.8% Q1'26: +30.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-1.19× Q1'26: -2.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-14 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
73.9K
OE per share TTM
0.00
Owner's Yield
0.42%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
221.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
15
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | David B. Musket | 6.21M | 4.33% | — | — | 4.18M | 2.04M | IN | Massachusetts | 2015-10-07 | ↗ |
| 2 | Alfred Sollami | 4.76M | 9.90% | — | 4.76M | — | — | HC, IN | Delaware | 2022-10-24 | ↗ |
| 3 | Auctus Fund Management LLC | 4.76M | 9.90% | — | 4.76M | — | — | IA, HC, OO | Delaware | 2022-10-24 | ↗ |
| 4 | Auctus Fund, LLC | 4.76M | 9.90% | — | 4.76M | — | — | PN | Delaware | 2022-10-24 | ↗ |
| 5 | Louis Posner | 4.76M | 9.90% | — | 4.76M | 4.76M | — | HC, IN | Delaware | 2022-10-24 | ↗ |
| 6 | The Whittemore Collection, Ltd. | 4.69M | 7.05% | — | 4.69M | — | 4.69M | CO | New York | 2014-01-29 | ↗ |
| 7 | George F. Landegger | 4.20M | 9.10% | — | 4.20M | — | — | IN | New York | 2010-09-21 | ↗ |
| 8 | Parsons & Whittemore Enterprises Corp. | 2.84M | 6.20% | — | 2.84M | — | — | CO | New York | 2010-09-21 | ↗ |
| 9 | S | 2.34M | 8.30% | — | 2.34M | — | 2.34M | IN | ONTARIO, CANADA | 2022-07-06 | ↗ |
| 10 | ProMed Partners, LP | 2.04M | 1.42% | — | — | — | 2.04M | PN | Massachusetts | 2015-10-07 | ↗ |
| 11 | Mr. Steven Derby | 929.7K | 5.32% | — | 929.7K | — | 929.7K | IN | United States | 2010-02-12 | ↗ |
| 12 | SDS Capital Group SPC, Ltd. | 929.7K | 5.32% | 929.7K | — | 929.7K | — | CO | Cayman Islands | 2010-02-12 | ↗ |
| 13 | SDS Management, LLC | 929.7K | 5.32% | — | 929.7K | — | 929.7K | CO | Delaware | 2010-02-12 | ↗ |
| 14 | Noro-Moseley Partners II, L.P. | 903.5K | 11.00% | 903.5K | — | 903.5K | — | PN | Georgia | 2000-01-07 | ↗ |
| 15 | 46-4896047 | 651.9K | 9.99% | 651.9K | — | 651.9K | — | OO | NEW YORK | 2016-04-18 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
4
Sells
0
Shares acquired
3.67M
Shares disposed
—
Cash buys
2.00
Cash sales
—
Net activity
+3,666,931
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Imhoff John E | Director / 10% Owner | C-Conversion | D | Convertible Promissory Note | 157,417 | 0.07 | 11.0K | 110,000 | D | ↗ |
| 2026-03-26 | Imhoff John E | Director / 10% Owner | J-Other | D | Preferred Series F Stock | 10 | 0.00 | — | 0 | D | ↗ |
| 2026-03-26 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common Stock | 352,000 | 0.00 | — | 10,391,311 | D | ↗ |
| 2026-03-10 | JAMES MICHAEL C | Director | A-Award | A | Stock Options | 110,000 | 0.29 | 31.9K | 110,000 | D | ↗ |
| 2026-03-10 | Imhoff John E | Director / 10% Owner | A-Award | A | Stock Options | 110,000 | 0.29 | 31.9K | 110,000 | D | ↗ |
| 2026-03-10 | Grujic Alan | Director | A-Award | A | Stock Options | 110,000 | 0.29 | 31.9K | 110,000 | D | ↗ |
| 2026-03-10 | Blumberg Richard P. | Director / 10% Owner | A-Award | A | Stock Options | 110,000 | 0.29 | 31.9K | 110,000 | D | ↗ |
| 2026-03-01 | Blumberg Richard P. | Director / 10% Owner | H-ExpireLong | D | Warrants | 900,000 | 0.30 | 270.0K | 2,700,000 | D | ↗ |
| 2026-02-27 | Imhoff John E | Director / 10% Owner | J-Other | D | Preferred Series E Stock | 100 | 0.00 | — | 0 | D | ↗ |
| 2026-02-25 | JAMES MICHAEL C | Director | X-InTheMoney | D | Warrants | 100,000 | 0.25 | 25.0K | 52,778 | D | ↗ |
| 2026-02-25 | Imhoff John E | Director / 10% Owner | X-InTheMoney | D | Warrants | 500,000 | 0.20 | 100.0K | 0 | D | ↗ |
| 2026-02-25 | Blumberg Richard P. | Director / 10% Owner | M-Exempt | D | Warrants | 1,000,000 | 0.20 | 200.0K | 0 | D | ↗ |
| 2026-02-02 | Imhoff John E | Director / 10% Owner | C-Conversion | A | Common Stock | 312,720 | 0.07 | 21.9K | 19,997,013 | D | ↗ |
| 2026-01-05 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 25,338 | 0.00 | — | 19,684,293 | D | ↗ |
| 2025-12-18 | Imhoff John E | Director / 10% Owner | C-Conversion | D | Convertible Promissory Note | 195,460 | 0.07 | 13.7K | 150,000 | D | ↗ |
| 2025-08-29 | JAMES MICHAEL C | Director | P-Purchase | A | Warrants | 27,778 | 0.25 | 6.9K | 52,778 | D | ↗ |
| 2025-08-29 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Common Stock | 166,667 | 0.18 | 30.0K | 19,463,495 | D | ↗ |
| 2025-08-29 | Grujic Alan | Director | P-Purchase | A | Common Stock | 152,108 | 0.00 | — | 1,817,541 | D | ↗ |
| 2025-08-21 | Imhoff John E | Director / 10% Owner | J-Other | D | Preferred Series E Stock | 300 | 0.00 | — | 100 | D | ↗ |
| 2025-08-21 | Grujic Alan | Director | J-Other | D | Preferred Series E Stock | 50 | 0.00 | — | 0 | D | ↗ |
| 2025-08-21 | Blumberg Richard P. | Director / 10% Owner | J-Other | D | Preferred Series E Stock | 233 | 0.00 | — | 0 | D | ↗ |
| 2025-06-03 | JAMES MICHAEL C | Director | A-Award | A | Stock Options | 110,000 | 0.14 | 15.4K | 110,000 | D | ↗ |
| 2025-06-03 | Imhoff John E | Director | A-Award | A | Stock Options | 110,000 | 0.14 | 15.4K | 110,000 | D | ↗ |
| 2025-06-03 | Grujic Alan | Director | A-Award | A | Stock Options | 110,000 | 0.14 | 15.4K | 110,000 | D | ↗ |
| 2025-06-03 | Blumberg Richard P. | Director / 10% Owner | A-Award | A | Stock Options | 110,000 | 0.14 | 15.4K | 110,000 | D | ↗ |
| 2025-04-10 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 6,365 | 0.00 | — | 17,992,380 | D | ↗ |
| 2025-04-10 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common Stock | 55,853 | 0.00 | — | 6,911,059 | D | ↗ |
| 2025-03-18 | JAMES MICHAEL C | Director | P-Purchase | A | Common Stock | 150,000 | 0.10 | 15.0K | 262,772 | D | ↗ |
| 2025-03-18 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Warrants | 1,000,000 | 0.13 | 130.0K | 1,000,000 | D | ↗ |
| 2025-03-13 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Preferred Series E Stock | 150 | 30,000.00 | 4.50M | 400 | D | ↗ |
| 2025-03-11 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 2,258,690 | 0.13 | 286.0K | 16,722,946 | D | ↗ |
| 2025-03-07 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Preferred Series C Stock | 286 | 112,934.50 | 32.30M | 286 | D | ↗ |
| 2025-03-06 | Imhoff John E | Director / 10% Owner | J-Other | D | Preferred Series D Stock | 300 | 0.00 | — | 0 | D | ↗ |
| 2025-01-17 | Imhoff John E | 10% Owner | J-Other | A | Common Stock | 35,312 | 0.00 | — | 8,762,756 | D | ↗ |
| 2024-12-18 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Common Stock | 1,615,385 | 0.13 | 210.0K | 8,727,444 | D | ↗ |
| 2024-10-15 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 36,161 | 0.16 | 5.6K | 7,112,059 | D | ↗ |
| 2024-10-14 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common Stock | 400,000 | 350,000.00 | 140.00B | 6,689,725 | D | ↗ |
| 2024-09-23 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Common Stock | 1,666,667 | 150,000.00 | 250.00B | 7,075,898 | D | ↗ |
| 2024-09-02 | Grujic Alan | Director | J-Other | D | Warrants | 800,000 | 0.50 | 400.0K | 500,000 | — | ↗ |
| 2024-09-01 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Warrants | 900,000 | 0.30 | 270.0K | 3,600,000 | D | ↗ |
| 2024-08-21 | Imhoff John E | Director | J-Other | A | Common Stock | 183,008 | 0.11 | 20.0K | 5,409,231 | — | ↗ |
| 2024-08-21 | Grujic Alan | Director | J-Other | A | Common Stock | 36,602 | 0.11 | 4.0K | 1,448,025 | — | ↗ |
| 2024-08-21 | Blumberg Richard P. | Director | J-Other | A | Common Stock | 170,563 | 0.11 | 18.6K | 6,289,725 | — | ↗ |
| 2024-08-02 | JAMES MICHAEL C | Director | J-Other | A | Warrants | 25,000 | 0.25 | 6.3K | 25,000 | — | ↗ |
| 2024-07-31 | Imhoff John E | Director / 10% Owner | J-Other | A | Warrants | 25,000 | 0.25 | 6.3K | 25,000 | — | ↗ |
| 2024-07-31 | Grujic Alan | Director | J-Other | A | Warrants | 25,000 | 0.25 | 6.3K | 25,000 | — | ↗ |
| 2024-07-15 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 48,327 | 0.12 | 5.6K | 5,226,223 | — | ↗ |
| 2024-07-09 | JAMES MICHAEL C | Director | A-Award | A | Stock Options | 100,000 | 0.12 | 12.0K | 250,000 | — | ↗ |
| 2024-07-09 | Imhoff John E | Director / 10% Owner | A-Award | A | Stock Options | 100,000 | 0.12 | 12.0K | 250,000 | — | ↗ |
| 2024-07-09 | Grujic Alan | Director | A-Award | A | Stock Options | 100,000 | 0.12 | 12.0K | 100,000 | — | ↗ |
| 2024-07-09 | Blumberg Richard P. | Director / 10% Owner | A-Award | A | Stock Options | 100,000 | 0.12 | 12.0K | 200,000 | — | ↗ |
| 2024-04-05 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 48,638 | 0.12 | 5.6K | 5,177,896 | — | ↗ |
| 2024-03-26 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 4,420 | 0.14 | 601.56 | 5,129,258 | — | ↗ |
| 2024-03-26 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common stock | 38,893 | 0.14 | 5.3K | 6,119,162 | — | ↗ |
| 2024-03-01 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common stock | 400,000 | 350,000.00 | 140.00B | 5,965,357 | — | ↗ |
| 2024-01-16 | Imhoff John E | 10% Owner | J-Other | A | Common Stock | 37,324 | 0.15 | 5.6K | 5,124,838 | — | ↗ |
| 2023-12-01 | Blumberg Richard P. | Director / 10% Owner | X-InTheMoney | D | Warrants | 1,642,500 | 0.12 | 197.1K | 0 | — | ↗ |
| 2023-11-16 | Blumberg Richard P. | Director / 10% Owner | J-Other | D | Warrants | 950,000 | 0.25 | 237.5K | 0 | — | ↗ |
| 2023-10-16 | Imhoff John E | 10% Owner | J-Other | A | Common Stock | 37,410 | 0.15 | 5.6K | 5,087,514 | — | ↗ |
| 2023-09-01 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common stock | 400,000 | 350,000.00 | 140.00B | 3,922,857 | — | ↗ |
| 2023-08-21 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 112,568 | 0.18 | 20.0K | 5,050,104 | — | ↗ |
| 2023-08-21 | Grujic Alan | Director | J-Other | A | Common Stock | 22,514 | 0.18 | 4.0K | 1,411,423 | — | ↗ |
| 2023-08-21 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common stock | 104,914 | 0.18 | 18.6K | 3,522,857 | — | ↗ |
| 2023-08-11 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Common Stock | 500,899 | 150,090.00 | 75.18B | 4,937,536 | — | ↗ |
| 2023-07-17 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 26,301 | 0.21 | 5.6K | 4,436,637 | — | ↗ |
| 2023-04-18 | Imhoff John E | Director / 10% Owner | J-Other | A | Common Stock | 22,393 | 0.25 | 5.6K | 4,410,336 | — | ↗ |
| 2023-03-31 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common stock | 76,978 | 0.27 | 20.9K | 3,417,943 | — | ↗ |
| 2023-03-15 | Blumberg Richard P. | Director / 10% Owner | X-InTheMoney | A | Common stock | 831,250 | 0.25 | 207.8K | 3,340,965 | — | ↗ |
| 2023-03-07 | Grujic Alan | Director | — | D | Common Stock | 0 | 0.00 | — | 1,388,909 | — | ↗ |
| 2023-03-01 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Common stock | 400,000 | 350,000.00 | 140.00B | 2,509,715 | — | ↗ |
| 2023-02-22 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Warrants | 831,250 | 0.20 | 166.3K | 831,250 | — | ↗ |
| 2023-02-15 | Blumberg Richard P. | Director / 10% Owner | J-Other | D | Warrants | 875,000 | 0.25 | 218.8K | 1,825,000 | — | ↗ |
| 2023-02-10 | JAMES MICHAEL C | Director / 10% Owner | A-Award | A | Stock Options | 100,000 | 0.26 | 26.0K | 150,000 | — | ↗ |
| 2023-02-10 | Imhoff John E | Director / 10% Owner | A-Award | A | Stock Options | 100,000 | 0.26 | 26.0K | 100,000 | — | ↗ |
| 2023-02-10 | Blumberg Richard P. | Director / 10% Owner | A-Award | A | Stock Options | 100,000 | 0.26 | 26.0K | 100,000 | — | ↗ |
| 2022-12-01 | Blumberg Richard P. | Director / 10% Owner | J-Other | A | Warrants | 950,000 | 0.25 | 237.5K | 2,700,000 | — | ↗ |
| 2022-09-02 | JAMES MICHAEL C | Director / 10% Owner | P-Purchase | A | Common Stock | 100,000 | 0.50 | 50.0K | 112,772 | — | ↗ |
| 2022-09-02 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Common Stock | 500,000 | 0.50 | 250.0K | 4,356,532 | — | ↗ |
| 2022-09-02 | Grujic Alan | Director | — | D | Warrants to Purchase Common Stock | 800,000 | 0.50 | 400.0K | 0 | — | ↗ |
| 2022-09-02 | Blumberg Richard P. | Director / 10% Owner | P-Purchase | A | Common Stock | 1,000,000 | 0.50 | 500.0K | 2,109,715 | — | ↗ |
| 2022-09-01 | JAMES MICHAEL C | Director / 10% Owner | P-Purchase | A | Warrants | 100,000 | 0.50 | 50.0K | 100,000 | — | ↗ |
| 2022-09-01 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Warrants | 500,000 | 0.50 | 250.0K | 500,000 | — | ↗ |
| 2022-09-01 | Grujic Alan | Director | — | D | Warrants to Purchase Common Stock | 500,000 | 0.65 | 325.0K | 0 | — | ↗ |
| 2022-09-01 | Blumberg Richard P. | Director / 10% Owner | P-Purchase | A | Warrants | 1,000,000 | 0.50 | 500.0K | 1,000,000 | — | ↗ |
| 2020-08-21 | Grujic Alan | Director | — | D | Series E Preferred Stock | 50 | 4,000.00 | 200.0K | 0 | — | ↗ |
| 2016-11-14 | Blumberg Richard P. | Director | — | D | Common Stock | 0 | 0.00 | — | 23 | — | ↗ |
| 2016-06-13 | Imhoff Lynne H | 10% Owner | — | D | Series B Tranche B Warrant | 912 | 75.00 | 68.4K | 0 | — | ↗ |
| 2015-09-04 | Imhoff Lynne H | 10% Owner | — | D | Series C Warrant | 60 | 640.00 | 38.4K | 0 | — | ↗ |
| 2015-06-30 | Imhoff John E | Director / 10% Owner | S-Sale | D | Warrants | 58,935 | 0.23 | 13.3K | 0 | — | ↗ |
| 2015-06-30 | Cartwright Gene S | Director / Officer | P-Purchase | A | Warrants | 117,780 | 0.09 | 10.6K | 117,780 | — | ↗ |
| 2015-06-30 | Blumberg Richard P. | Director | — | D | Common Stock Warrant (Right to Buy) | 3 | 822.00 | 2.5K | 0 | — | ↗ |
| 2015-06-29 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Common Stock | 18,752 | 0.00 | — | 9,904,725 | — | ↗ |
| 2015-06-29 | HART RONALD W | Director | P-Purchase | A | Common Stock | 5,682 | 0.00 | — | 696,748 | — | ↗ |
| 2015-06-29 | Cartwright Gene S | Director / Officer | P-Purchase | A | Common Stock | 37,504 | 0.12 | 4.5K | 2,235,739 | — | ↗ |
| 2015-06-19 | Imhoff John E | Director / 10% Owner | S-Sale | D | Tranche A Warrants | 367,647 | 1.08 | 397.1K | 0 | — | ↗ |
| 2015-06-19 | HART RONALD W | Director | S-Sale | D | Tranche A Warrants | 18,382 | 1.08 | 19.9K | 0 | — | ↗ |
| 2015-05-29 | Imhoff John E | Director / 10% Owner | A-Award | A | Options | 600,000 | 0.10 | 60.0K | 600,000 | — | ↗ |
| 2015-05-29 | HART RONALD W | Director | A-Award | A | Options | 600,000 | 0.10 | 60.0K | 1,255,000 | — | ↗ |
| 2015-04-08 | Imhoff John E | Director / 10% Owner | A-Award | A | Common Stock | 78,125 | 0.16 | 12.5K | 9,772,337 | — | ↗ |
| 2015-04-08 | HART RONALD W | Director | S-Sale | A | Common Stock | 3,906 | 0.16 | 624.96 | 691,066 | — | ↗ |
| 2015-03-16 | Blumberg Richard P. | Director | — | D | Common Stock Warrant (Right to Buy) | 5 | 20,400.00 | 102.0K | 0 | — | ↗ |
| 2015-01-16 | Imhoff John E | Director / 10% Owner | A-Award | A | Common Stock | 54,348 | 0.23 | 12.5K | 9,694,212 | — | ↗ |
| 2015-01-16 | HART RONALD W | Director | S-Sale | A | Common Stock | 2,717 | 0.23 | 624.91 | 687,160 | — | ↗ |
| 2014-12-02 | Blumberg Richard P. | Director | — | D | Common Stock Warran (Right to Buy) | 3 | 822.00 | 2.5K | 0 | — | ↗ |
| 2014-11-26 | Imhoff John E | Director / 10% Owner | J-Other | A | Warrants to purchase Common Stock | 58,965 | 0.23 | 13.3K | 58,965 | — | ↗ |
| 2014-11-26 | Cartwright Gene S | Director / Officer | J-Other | A | Common Stock | 235,739 | 0.23 | 53.0K | 2,335,739 | — | ↗ |
| 2014-10-20 | Imhoff John E | Director / 10% Owner | A-Award | A | Common Stock | 39,063 | 0.32 | 12.5K | 9,521,994 | — | ↗ |
| 2014-10-20 | HART RONALD W | Director | S-Sale | A | Common Stock | 1,953 | 0.32 | 624.96 | 1,313,154 | — | ↗ |
| 2014-08-14 | ROSENSTOCK LINDA | Director | A-Award | A | Common Stock | 152,174 | 0.46 | 70.0K | 287,174 | — | ↗ |
| 2014-08-14 | Niloff Jonathan M | Director | A-Award | A | Common Stock | 152,174 | 0.46 | 70.0K | 339,466 | — | ↗ |
| 2014-08-14 | Imhoff John E | Director / 10% Owner | A-Award | A | Common Stock | 152,174 | 0.46 | 70.0K | 9,416,963 | — | ↗ |
| 2014-08-14 | HART RONALD W | Director | A-Award | A | Common Stock | 152,174 | 0.46 | 70.0K | 1,311,201 | — | ↗ |
| 2014-07-02 | HART RONALD W | Director | S-Sale | D | Common stock | 7,500 | 0.50 | 3.8K | 1,159,027 | — | ↗ |
| 2014-06-24 | HART RONALD W | Director | D-Return | D | Common Stock | 12,500 | 0.50 | 6.3K | 1,166,527 | — | ↗ |
| 2014-06-20 | Cartwright Gene S | Director / Officer | P-Purchase | A | Common Stock | 27,000 | 0.49 | 13.1K | 2,100,000 | — | ↗ |
| 2014-06-19 | Cartwright Gene S | Director / Officer | P-Purchase | A | Common Stock | 23,000 | 0.48 | 11.1K | 2,073,000 | — | ↗ |
| 2014-06-18 | Cartwright Gene S | Director / Officer | P-Purchase | A | Common Stock | 26,000 | 0.49 | 12.6K | 2,050,000 | — | ↗ |
| 2014-06-17 | Cartwright Gene S | Director / Officer | P-Purchase | A | Common Stock | 24,000 | 0.49 | 11.7K | 2,024,000 | — | ↗ |
| 2014-06-02 | HART RONALD W | Director | S-Sale | D | Common Stock | 12,500 | 0.50 | 6.3K | 1,166,527 | — | ↗ |
| 2014-05-29 | HART RONALD W | Director | S-Sale | D | Common Stock | 12,500 | 0.50 | 6.3K | 1,179,027 | — | ↗ |
| 2014-01-06 | Cartwright Gene S | Director / Officer | A-Award | A | Common Stock | 2,000,000 | 0.00 | — | 2,000,000 | — | ↗ |
| 2013-11-27 | Imhoff John E | Director / 10% Owner | M-Exempt | A | Warrants | 1,466,420 | 0.40 | 586.6K | 0 | — | ↗ |
| 2013-11-27 | ALLEN RONALD W | Director | A-Award | A | Warrants | 58,333 | 0.40 | 23.3K | 58,333 | — | ↗ |
| 2013-11-13 | Imhoff John E | Director / 10% Owner | A-Award | A | Warrants | 1,466,420 | 0.40 | 586.6K | 1,466,420 | — | ↗ |
| 2013-07-26 | Imhoff John E | Director / 10% Owner | M-Exempt | A | Common Stock | 128,221 | 0.65 | 83.3K | 7,798,369 | — | ↗ |
| 2013-05-23 | Landegger George F | 10% Owner | P-Purchase | A | Series B Convertible Preferred Stock | 100 | 0.68 | 68.00 | 100 | — | ↗ |
| 2013-05-23 | Imhoff Lynne H | 10% Owner | — | D | Series B Tranche A Warrant | 1 | 864.00 | 864.00 | 0 | — | ↗ |
| 2013-05-23 | Imhoff John E | Director / 10% Owner | P-Purchase | A | Series B-Preferred Stock | 500 | 0.68 | 340.00 | 500 | — | ↗ |
| 2013-05-23 | HART RONALD W | Director | P-Purchase | A | Warrants to Purchase Common Stock-B | 18,383 | 1.08 | 19.9K | 18,383 | — | ↗ |
| 2013-03-28 | ROSENSTOCK LINDA | Director | A-Award | A | Options | 18,750 | 0.69 | 12.9K | 18,750 | — | ↗ |
| 2013-03-28 | Niloff Jonathan M | Director | A-Award | A | Options | 25,000 | 0.69 | 17.3K | 25,000 | — | ↗ |
| 2013-03-28 | Imhoff John E | Director / 10% Owner | A-Award | A | Common Stock | 78,750 | 0.00 | — | 7,670,148 | — | ↗ |
| 2013-03-28 | HART RONALD W | Director | A-Award | A | Options | 25,000 | 0.80 | 20.0K | 25,000 | — | ↗ |
| 2013-03-28 | ALLEN RONALD W | Director | A-Award | A | Options | 25,000 | 0.69 | 17.3K | 25,000 | — | ↗ |
| 2013-03-22 | FAUPEL MARK L | Officer | A-Award | A | Options | 35,000 | 0.67 | 23.5K | 35,000 | — | ↗ |
| 2013-02-28 | HART RONALD W | Director | A-Award | A | Common Stock | 150,938 | 0.00 | — | 1,127,017 | — | ↗ |
| 2012-08-21 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 10,000 | 0.71 | 7.1K | 348,368 | — | ↗ |
| 2012-08-20 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 2,500 | 0.73 | 1.8K | 380,868 | — | ↗ |
| 2012-08-15 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 1,000 | 0.84 | 840.00 | 383,368 | — | ↗ |
| 2012-08-08 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 6,500 | 0.84 | 5.5K | 395,868 | — | ↗ |
| 2012-08-07 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 6,000 | 0.85 | 5.1K | 402,368 | — | ↗ |
| 2012-08-02 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 4,600 | 0.90 | 4.1K | 408,368 | — | ↗ |
| 2012-08-01 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 7,560 | 0.94 | 7.1K | 413,068 | — | ↗ |
| 2012-07-26 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.85 | 10.6K | 420,868 | — | ↗ |
| 2012-07-16 | Imhoff John E | Director / 10% Owner | M-Exempt | A | Common Stock | 1,594,641 | 0.40 | 637.9K | 7,591,398 | — | ↗ |
| 2012-07-12 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 3,300 | 0.69 | 2.3K | 433,368 | — | ↗ |
| 2012-07-11 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 5,300 | 0.69 | 3.7K | 446,368 | — | ↗ |
| 2012-07-10 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 3,100 | 0.60 | 1.9K | 451,668 | — | ↗ |
| 2012-07-06 | JAMES MICHAEL C | Director | A-Award | A | Common Stock Warrants (Right to Buy) | 51,282 | 0.00 | — | 1,470,722 | — | ↗ |
| 2012-07-06 | Imhoff John E | Director / 10% Owner | A-Award | A | Common Stock Warrants (Right to Buy) | 128,221 | 0.00 | — | 4,783,923 | — | ↗ |
| 2012-07-06 | HART RONALD W | Director | A-Award | A | Common Stock Warrants (Right to Buy) | 51,282 | 0.80 | 41.0K | 51,282 | — | ↗ |
| 2012-07-06 | ALLEN RONALD W | Director | A-Award | A | Common Stock Warrants (Right to Buy) | 58,333 | 0.80 | 46.7K | 58,333 | — | ↗ |
| 2012-06-26 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.76 | 9.5K | 458,368 | — | ↗ |
| 2012-06-26 | FOWLER RICHARD | Officer | A-Award | A | Common Stock | 10,892 | 0.79 | 8.6K | 98,115 | — | ↗ |
| 2012-06-26 | FAUPEL MARK L | Officer | A-Award | A | Common Stock | 13,630 | 0.79 | 10.8K | 267,476 | — | ↗ |
| 2012-06-21 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 1,000 | 0.69 | 690.00 | 488,368 | — | ↗ |
| 2012-06-20 | ALLEN RONALD W | Director | A-Award | A | Common Stock Warrants (Right to Buy) | 125,869 | 0.00 | — | 125,869 | — | ↗ |
| 2012-06-19 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 500 | 0.76 | 380.00 | 500,368 | — | ↗ |
| 2012-06-18 | Bambot Shabbir Bakir | Director / Officer | A-Award | A | Employee Stock Options (Right to Buy) | 24,461 | 0.30 | 7.3K | 710,539 | — | ↗ |
| 2012-06-16 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 5,500 | 0.75 | 4.1K | 494,868 | — | ↗ |
| 2012-06-15 | HART RONALD W | Director | M-Exempt | A | Common Stock | 21,522 | 0.40 | 8.6K | 711,060 | — | ↗ |
| 2012-06-13 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 4,000 | 0.75 | 3.0K | 500,868 | — | ↗ |
| 2012-06-06 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.77 | 9.6K | 513,368 | — | ↗ |
| 2012-06-01 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 10,000 | 0.62 | 6.2K | 525,868 | — | ↗ |
| 2012-05-25 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 3,900 | 0.75 | 2.9K | 538,368 | — | ↗ |
| 2012-05-16 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 4,600 | 0.78 | 3.6K | 558,768 | — | ↗ |
| 2012-05-09 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.83 | 10.4K | 563,368 | — | ↗ |
| 2012-05-02 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 7,100 | 0.80 | 5.7K | 575,868 | — | ↗ |
| 2012-05-01 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 5,400 | 0.83 | 4.5K | 582,968 | — | ↗ |
| 2012-04-24 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 2,500 | 0.84 | 2.1K | 592,968 | — | ↗ |
| 2012-04-17 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 7,500 | 0.85 | 6.3K | 600,868 | — | ↗ |
| 2012-04-16 | ROSENSTOCK LINDA | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2012-04-11 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 4,300 | 0.86 | 3.7K | 621,568 | — | ↗ |
| 2012-04-02 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.90 | 11.3K | 625,868 | — | ↗ |
| 2012-03-28 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.89 | 11.1K | 638,368 | — | ↗ |
| 2012-03-20 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.96 | 12.0K | 650,868 | — | ↗ |
| 2012-03-12 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.98 | 12.3K | 663,368 | — | ↗ |
| 2012-03-12 | Bambot Shabbir Bakir | Officer | D-Return | D | Common Stock | 15,000 | 1.00 | 15.0K | 0 | — | ↗ |
| 2012-03-05 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 3,900 | 0.90 | 3.5K | 684,468 | — | ↗ |
| 2012-03-01 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.75 | 9.4K | 688,368 | — | ↗ |
| 2012-02-21 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 2,500 | 0.70 | 1.8K | 710,868 | — | ↗ |
| 2012-02-13 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 2,500 | 0.71 | 1.8K | 723,368 | — | ↗ |
| 2012-02-10 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 16,500 | 0.70 | 11.5K | 728,768 | — | ↗ |
| 2012-01-27 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 10,000 | 0.68 | 6.8K | 750,868 | — | ↗ |
| 2012-01-20 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 9,500 | 1.42 | 13.5K | 763,368 | — | ↗ |
| 2012-01-11 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 10,000 | 1.69 | 16.9K | 778,368 | — | ↗ |
| 2012-01-05 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 8,000 | 1.78 | 14.2K | 792,868 | — | ↗ |
| 2012-01-03 | Bambot Shabbir Bakir | Officer | A-Award | D | Common Stock | 7,500 | 0.30 | 2.3K | 7,500 | — | ↗ |
| 2011-12-28 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 4,142 | 1.42 | 5.9K | 807,516 | — | ↗ |
| 2011-12-21 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 10,000 | 1.50 | 15.0K | 813,368 | — | ↗ |
| 2011-12-20 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 1,800 | 1.50 | 2.7K | 823,368 | — | ↗ |
| 2011-12-16 | FOWLER RICHARD | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 125,000 | 1.47 | 183.8K | 461,000 | — | ↗ |
| 2011-12-16 | FAUPEL MARK L | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 130,000 | 1.47 | 191.1K | 2,136,000 | — | ↗ |
| 2011-12-16 | Bambot Shabbir Bakir | Officer | A-Award | A | Employee Stock Options (Right to Buy) | 120,000 | 1.47 | 176.4K | 757,500 | — | ↗ |
| 2011-12-13 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 2,071 | 1.34 | 2.8K | 825,868 | — | ↗ |
| 2011-12-13 | Bambot Shabbir Bakir | Officer | A-Award | D | Common Stock | 5,000 | 0.24 | 1.2K | 22,500 | — | ↗ |
| 2011-12-05 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 12,500 | 0.96 | 12.0K | 838,368 | — | ↗ |
| 2011-12-01 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 8,800 | 0.95 | 8.4K | 854,568 | — | ↗ |
| 2011-11-22 | Landegger George F | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 115,900 | — | ↗ |
| 2011-11-22 | JAMES MICHAEL C | Director | D-Return | D | Common Stock | 10,000 | 0.94 | 9.4K | 863,368 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-6.4K
Shares Outstanding
76.70M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2015 | Gene S. Cartwright, Ph.D. President, CEO, Acting CFO and Director | 300.0K | 150.0K | — | — | — | — | 450.0K | 0.00% | ↗ |
| 2 | 2015 | Mark Faupel, Ph.D. Former President, CEO and Acting CFO | 198.1K | — | — | 30.4K | — | — | 228.5K | 13.31% | ↗ |
| 3 | 2014 | Gene S. Cartwright, Ph.D. President, CEO, Acting CFO and Director | 300.0K | 150.0K | — | 731.0K | — | — | 1.05M | 69.89% | ↗ |
| 4 | 2014 | Mark Faupel, Ph.D. Former President, CEO and Acting CFO | 264.1K | 13.6K | — | 17.0K | — | — | 294.7K | 5.77% | ↗ |
| 5 | 2014 | Shabbir Bambot, Ph.D. Former Vice President of Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 6 | 2013 | Mark Faupel, Ph.D. Former President, CEO and Acting CFO | 243.0K | — | — | 24.0K | — | — | 267.0K | 8.99% | ↗ |
| 7 | 2013 | Mark Faupel, Ph.D. President, CEO, Acting CFO and Director | 243.0K | — | — | — | — | — | 243.0K | 0.00% | ↗ |
| 8 | 2013 | Shabbir Bambot, Ph.D. Vice President of Research and Development | 80.2K | — | — | — | — | — | 80.2K | 0.00% | ↗ |
| 9 | 2013 | Shabbir Bambot, Ph.D. Former Vice President of Research and Development | 80.2K | — | — | — | — | — | 80.2K | 0.00% | ↗ |
| 10 | 2013 | Gene S. Cartwright, Ph.D. President, CEO, Acting CFO and Director | — | — | — | — | — | — | — | — | ↗ |
| 11 | 2012 | Mark Faupel, Ph.D. President, CEO, Acting CFO and Director | 243.0K | — | — | 214.5K | — | — | 457.0K | 46.94% | ↗ |
| 12 | 2012 | Shabbir Bambot, Ph.D. Vice President of Research and Development | 193.0K | — | — | 6.0K | — | — | 193.0K | 3.11% | ↗ |
| 13 | 2011 | Mark Faupel, Ph.D. President, CEO Acting CFO | 243.0K | — | — | 214.5K | — | — | 457.5K | 46.89% | ↗ |
| 14 | 2011 | Mark Faupel, Ph.D. President, CEO, Acting CFO and Director | 243.0K | — | — | 214.5K | — | — | 457.0K | 46.94% | ↗ |
| 15 | 2011 | Shabbir Bambot, Ph.D. Vice President of Research and Development | 183.8K | — | — | 6.0K | — | — | 189.8K | 3.16% | ↗ |
| 16 | 2011 | Richard Fowler Senior Vice President of Engineering | 173.4K | — | — | 6.3K | — | — | 179.7K | 3.48% | ↗ |
| 17 | 2010 | Mark Faupel, Ph.D. President, CEO Acting CFO | 228.0K | — | — | 520.0K | — | — | 748.0K | 69.52% | ↗ |
| 18 | 2010 | Shabbir Bambot, Ph.D. Vice President of Research and Development | 175.0K | — | — | — | — | — | 175.0K | 0.00% | ↗ |
| 19 | 2010 | Richard Fowler Senior Vice President of Engineering | 170.0K | — | — | — | — | — | 170.0K | 0.00% | ↗ |
| 20 | 2009 | Mark Faupel, Ph.D. President, CEO Acting CFO | 228.0K | — | — | 380.0K | — | — | 608.0K | 62.50% | ↗ |
| 21 | 2009 | Mark Faupel, Ph.D, CEO CFO | 228.0K | — | — | 380.0K | — | — | 608.0K | 62.50% | ↗ |
| 22 | 2009 | Shabbir Bambot, Ph.D. Vice President of RD | 175.0K | 7.5K | — | — | — | — | 182.5K | 0.00% | ↗ |
| 23 | 2009 | Shabbir Bambot, Ph.D. Vice President of Research and Development | 175.0K | 7.5K | — | — | — | — | 182.5K | 0.00% | ↗ |
| 24 | 2009 | Richard Fowler, Sr. Vice President of Engineering | 170.0K | — | — | — | — | — | 170.0K | 0.00% | ↗ |
| 25 | 2009 | Richard Fowler Senior Vice President of Engineering | 170.0K | — | — | — | — | — | 170.0K | 0.00% | ↗ |
| 26 | 2008 | Shabbir Bambot, Ph.D. Vice President of RD | 160.0K | — | — | 85.8K | — | — | 245.8K | 34.91% | ↗ |
| 27 | 2008 | Mark Faupel, Ph.D, CEO CFO | 228.0K | — | — | — | — | — | 228.0K | 0.00% | ↗ |
| 28 | 2008 | Richard Fowler, Sr. Vice President of Engineering | 170.0K | — | — | — | — | — | 170.0K | 0.00% | ↗ |
| 29 | 2007 | Mark Faupel, Ph.D CEO CFO | 160.0K | — | — | — | — | — | 160.0K | 0.00% | ↗ |
| 30 | 2007 | Mark A. Samuels Former Chairman, CEO CFO | 114.6K | — | — | — | — | 5.3K | 119.9K | 0.00% | ↗ |
| 31 | 2007 | William D. Arthur Former President COO, Secretary | 80.0K | — | — | — | — | — | 80.0K | 0.00% | ↗ |
| 32 | 2007 | Shabbir Bambot, Ph.D VP of RD | 143.0K | — | — | 2.5K | — | — | 2.5K | 100.00% | ↗ |
| 33 | 2007 | Richard Fowler Senior VP of Engineering | 170.0K | — | — | 1.9K | — | — | 1.9K | 100.00% | ↗ |
| 34 | 2006 | Mark A. Samuels, Former Chairman, CEO CFO | 237.6K | — | — | — | — | 4.9K | 242.5K | 0.00% | ↗ |
| 35 | 2006 | Mark A. Samuels Former Chairman, CEO CFO | 237.6K | — | — | — | — | 4.9K | 242.5K | 0.00% | ↗ |
| 36 | 2006 | Mark Faupel, Ph.D CEO President | 163.7K | — | — | — | — | — | 163.7K | 0.00% | ↗ |
| 37 | 2006 | Mark Faupel, Ph.D CEO CFO | 163.7K | — | — | — | — | — | 163.7K | 0.00% | ↗ |
| 38 | 2006 | William D. Arthur, Former President COO, Secretary | 151.3K | — | — | — | — | — | 151.3K | 0.00% | ↗ |
| 39 | 2006 | William D. Arthur Former President COO, Secretary | 151.3K | — | — | — | — | — | 151.3K | 0.00% | ↗ |
| 40 | 2006 | Richard Fowler Senior VP of Engineering | 135.0K | — | — | — | — | — | 135.0K | 0.00% | ↗ |
| 41 | 2006 | Shabbir Bambot, Ph.D VP of RD | 120.0K | — | — | — | — | — | 120.0K | 0.00% | ↗ |
| 42 | 2005 | Mark A. Samuels, Former Chairman, CEO CFO | 232.4K | — | — | 45.8K | — | 10.4K | 288.6K | 15.86% | ↗ |
| 43 | 2005 | William D. Arthur, Former President COO, Secretary | 180.1K | — | — | 58.5K | — | — | 238.6K | 24.52% | ↗ |
| 44 | 2005 | Mark Faupel, Ph.D CEO President | 164.9K | — | — | 22.1K | — | — | 187.0K | 11.82% | ↗ |
| 45 | 2005 | Mark A. Samuels Chairman, Chief Executive Officer Chief Financial Officer | 158.9K | — | — | — | — | 10.5K | 169.4K | 0.00% | ↗ |
| 46 | 2005 | Mark L. Faupel Executive Vice President, Chief Technical Officer | 131.2K | — | — | — | — | — | 131.2K | 0.00% | ↗ |
| 47 | 2005 | Walter Pavlicek Vice President, Operations | 108.6K | — | — | — | — | — | 108.6K | 0.00% | ↗ |
| 48 | 2005 | Richard L. Fowler Senior Vice President Engineering | 101.2K | — | — | — | — | — | 101.2K | 0.00% | ↗ |
| 49 | 2005 | William D. Arthur, III. President, Chief Operating Officer and Secretary | 80.4K | — | — | — | — | — | 80.4K | 0.00% | ↗ |
| 50 | 2004 | Mark A. Samuels Chairman, Chief Executive Officer Chief Financial Officer | 234.1K | — | — | — | — | 11.9K | 246.0K | 0.00% | ↗ |
| 51 | 2004 | William D. Arthur, III. President, Chief Operating Officer and Secretary | 174.2K | — | — | — | — | — | 174.2K | 0.00% | ↗ |
| 52 | 2004 | Walter Pavlicek Vice President, Operations | 135.0K | — | — | — | — | — | 135.0K | 0.00% | ↗ |
| 53 | 2004 | Mark L. Faupel Executive Vice President, Chief Technical Officer | 128.5K | — | — | — | — | — | 128.5K | 0.00% | ↗ |
| 54 | 2004 | Richard L. Fowler Senior Vice President Engineering | 96.6K | — | — | — | — | — | 96.6K | 0.00% | ↗ |
| 55 | 2003 | Mark A. Samuels Chairman, Chief Executive Officer Chief Financial Officer | 230.6K | — | — | — | — | 3.2K | 233.8K | 0.00% | ↗ |
| 56 | 2003 | Mark L. Faupel Executive Vice President, Chief Technical Officer | 143.3K | — | — | — | — | — | 143.3K | 0.00% | ↗ |
| 57 | 2003 | Walter Pavlicek Vice President, Operations | 129.5K | — | — | — | — | — | 129.5K | 0.00% | ↗ |
| 58 | 2003 | Richard L. Fowler Senior Vice President Engineering | 121.5K | — | — | — | — | — | 121.5K | 0.00% | ↗ |
| 59 | 2003 | William D. Arthur, III. President, Chief Operating Officer and Secretary | 13.6K | — | — | — | — | — | 13.6K | 0.00% | ↗ |
| 60 | 2001 | Mark A. Samuels Chairman and Chief Executive Officer | 227.5K | 25.0K | — | — | — | 3.1K | 255.7K | 0.00% | ↗ |
| 61 | 2000 | Mark A. Samuels Chairman and Chief Executive Officer | 220.0K | 63.3K | — | — | — | 3.1K | 286.4K | 0.00% | ↗ |
| 62 | 1999 | Mark A. Samuels Chairman and Chief Executive Officer | 200.0K | 50.0K | — | — | — | 3.1K | 253.1K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mark L. Faupel | Chief Executive Officer, President, Chief Operating Officer, Acting Chief Financial Officer, Secretary & Director | 248.4K | — |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GTHP
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
